v3.26.1
Stockholders' Equity
 9 Months Ended
Jul. 31, 2026
Equity [Abstract]  
Stockholders' Equity 12: Stockholders' Equity
The components of accumulated other comprehensive loss, net of taxes as of July 31, 2026, and changes for the nine months ended July 31, 2026 were as follows:
Net unrealized gains (losses)
on
available-for-sale
securities		Net unrealized (losses) gains
on cash
flow hedges		Unrealized
components
of defined
benefit plans		Cumulative
translation
adjustment		Accumulated
other
comprehensive
loss
In millions
Balance at beginning of period$6 $(26)$(2,058)$(670)$(2,748)
Other comprehensive (loss) income before reclassifications(1)26 5 (43)(13)
Reclassifications of losses into earnings— 3 76 — 79 
Tax provision— (2)(18)— (20)
Balance at end of period$5 $1 $(1,995)$(713)$(2,702)
The components of accumulated other comprehensive loss, net of taxes as of July 31, 2025, and changes for the nine months ended July 31, 2025 were as follows:
Net unrealized
 gains (losses) on
available-for-sale
securities		Net unrealized (losses) gains on cash
flow hedges		Unrealized
components
of defined
benefit plans		Cumulative
translation
adjustment		Accumulated
other
comprehensive
loss
In millions
Balance at beginning of period$8 $(16)$(2,342)$(627)$(2,977)
Other comprehensive loss before reclassifications(5)(189)(10)(28)(232)
Reclassifications of losses into earnings— 87 98 — 185 
Tax benefit (provision)— 16 (16)— — 
Balance at end of period$3 $(102)$(2,270)$(655)$(3,024)
Share Repurchase Program
For the nine months ended July 31, 2026, the Company repurchased and settled 16.5 million shares under its share repurchase program through open market repurchases. As of July 31, 2026, the Company’s unsettled open market repurchases were immaterial. Shares repurchased for the nine months ended July 31, 2026 were recorded as a $450 million reduction to stockholders’ equity. As of July 31, 2026, the Company had a remaining authorization of approximately $3.2 billion for future share repurchases.
Warrant
On July 2, 2026, the Company issued a warrant (the "Warrant") to Oracle Corp. ("Holder") to purchase up to an
aggregate of 4,156,466 shares of the Company’s common stock at an exercise price of $0.01 per share. The Warrant was issued in connection with the Holder entering into a strategic collaboration with the Company to deploy the Company’s networking solutions in the Holder’s AI data centers. The Warrant will vest and become exercisable in tranches, upon the achievement of specific milestones relating to purchases by the Holder and its affiliates of products and support from the Company. Subject to the terms of the Warrant, the Warrant is exercisable through June 25, 2029.